Cargando…
Microsatellite Instability, Epstein–Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer
SIMPLE SUMMARY: Immunotherapy is approved in selected cases of gastric cancer, and durable responses have been observed in exceptional responders. Several potential predictive biomarkers have been identified in gastric cancer, such as microsatellite instability-high (MSI-H), Epstein–Barr virus (EBV)...
Autores principales: | Yu, Hung-Yuan, Li, Chung-Pin, Huang, Yi-Hsiang, Hsu, Shao-Jung, Wang, Yen-Po, Hsieh, Yun-Cheng, Fang, Wen-Liang, Huang, Kuo-Hung, Li, Anna Fen-Yau, Lee, Rheun-Chuan, Lee, Kang-Lung, Wu, Yuan-Hung, Lai, I-Chun, Yang, Wan-Chin, Hung, Yi-Ping, Wang, Yu-Chao, Chen, Shu-Hui, Chen, Ming-Huang, Chao, Yee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750088/ https://www.ncbi.nlm.nih.gov/pubmed/35008382 http://dx.doi.org/10.3390/cancers14010218 |
Ejemplares similares
-
The Clinicopathological Features and Genetic Alterations in Epstein–Barr Virus-Associated Gastric Cancer Patients after Curative Surgery
por: Fang, Wen-Liang, et al.
Publicado: (2020) -
Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study
por: Chen, San-Chi, et al.
Publicado: (2022) -
Regulation of Epstein-Barr Virus Minor Capsid Protein BORF1 by TRIM5α
por: Lin, Lih-Tsern, et al.
Publicado: (2022) -
Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma
por: Chiu, Shih-Hsin, et al.
Publicado: (2014) -
Lenvatinib combined with nivolumab in advanced hepatocellular carcinoma-real-world experience
por: Wu, Wen-Chi, et al.
Publicado: (2022)